Clinical Trial Update: Comparison of the Effectiveness of Brexpiprazole With That of Risperidone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing brexpiprazole with risperidone for schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• REXULTI (brexpiprazole)
• Risperdal (risperidone)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: WITHDRAWN